The patient's sample is added to the port, where antibodies targeting the virus fusion protein can bind the antigen in the sample. Capillary action migrates the resultant complex along the strip ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like ...

Respiratory syncytial virus (RSV) infections are the leading ... is a humanized murine monoclonal antibody against the RSV fusion protein that prevents the spread of virus to the lower respiratory ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...

At the recent SEC meeting for antimicrobials and antivirals held on 22nd August 2024, the expert panel reviewed Protocol ...

As a paediatrician in training, Jacqueline Miller was struck by how, every winter, she saw a steep rise in the numbers of patients with two conditions: respiratory syncytial virus (RSV ...

Most of the antiviral agents that have been approved, and are currently used in the treatment of virus infections, are targeted at HIV, HBV, herpes simplex virus (HSV), varicella-zoster virus (VZV ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...